Stamos Capital Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.14M | Buy |
185,992
+40,613
| +28% | +$1.56M | 1.28% | 19 |
|
|
2025
Q1 | $5.63M | Sell |
145,379
-149,441
| -51% | -$5.79M | 1.47% | 12 |
|
|
2024
Q4 | $9.97M | Buy |
294,820
+87,630
| +42% | +$2.96M | 2.34% | 8 |
|
|
2024
Q3 | $8.47M | Buy |
207,190
+16,710
| +9% | +$683K | 1.99% | 8 |
|
|
2024
Q2 | $7.33M | Sell |
190,480
-470
| -0.2% | -$18.1K | 1.56% | 11 |
|
|
2024
Q1 | $8.19M | Buy |
190,950
+19,780
| +12% | +$848K | 1.86% | 10 |
|
|
2023
Q4 | $6.34M | Buy |
171,170
+67,660
| +65% | +$2.51M | 1.72% | 14 |
|
|
2023
Q3 | $3.75M | Buy |
103,510
+9,740
| +10% | +$353K | 0.84% | 28 |
|
|
2023
Q2 | $3.34M | Buy |
+93,770
| New | +$3.34M | 0.78% | 37 |
|
|
2022
Q4 | – | Sell |
-68,530
| Closed | -$2.02M | – | 150 |
|
|
2022
Q3 | $2.02M | Sell |
68,530
-85,870
| -56% | -$2.53M | 0.51% | 51 |
|
|
2022
Q2 | $8.4M | Hold |
154,400
| – | – | 2.54% | 15 |
|
|
2022
Q1 | $8.41M | Buy |
154,400
+45,760
| +42% | +$2.49M | 2.81% | 11 |
|
|
2021
Q4 | $5.99M | Buy |
108,640
+25,128
| +30% | +$1.39M | 2.78% | 13 |
|
|
2021
Q3 | $3.99M | Hold |
83,512
| – | – | 2.23% | 22 |
|
|
2021
Q2 | $4.16M | Sell |
83,512
-1,048
| -1% | -$52.2K | 2.19% | 21 |
|
|
2021
Q1 | $3.77M | Hold |
84,560
| – | – | 1.9% | 25 |
|
|
2020
Q4 | $3.89M | Buy |
+84,560
| New | +$3.89M | 1.66% | 22 |
|
|
2020
Q2 | – | Sell |
-21,822
| Closed | -$1.03M | – | 73 |
|
|
2020
Q1 | $1.03M | Buy |
+21,822
| New | +$1.03M | 0.54% | 55 |
|
|
2019
Q3 | – | Sell |
-4,800
| Closed | -$243K | – | 48 |
|
|
2019
Q2 | $243K | Sell |
4,800
-5,600
| -54% | -$284K | 0.24% | 51 |
|
|
2019
Q1 | $525K | Sell |
10,400
-10,400
| -50% | -$525K | 0.67% | 42 |
|
|
2018
Q4 | $993K | Buy |
+20,800
| New | +$993K | 0.75% | 42 |
|